I lead the Infectious Disease Epidemiology and Analytics (IDEA) G5 Unit in the Department of Global Health at Institut Pasteur. Our team uses inter-disciplinary research tools spanning mathematical models, epidemiological cohort studies, and multiplex assays to investigate the epidemiology of infectious diseases. A key goal is the development of multiplex assays and statistical tools for integrated surveillance of multiple pathogens. Despite this multi-pathogen focus, I have a special fondness for malaria and neglected tropical diseases, and my favourite parasite is definitely Plasmodium vivax. Like many other researchers, I have developed an interest in coronaviruses, and have made some small contributions in the development of novel serological assays.
Click to view graph
Connections
Click to view timeline
Timeline
Projects
Publications
Download-
2021How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites., Malar J 2021 Dec; 20(1): 479.
-
2021Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation., Math Biosci 2021 Dec; 343(): 108750.
-
2021Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 11; 224(9): 1489-1499.
-
2021Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Jul; 70(): 103495.
-
2021Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination., Med (N Y) 2021 Jun; 2(6): 701-719.e19.
-
2021IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection., Open Forum Infect Dis 2021 Jun; 8(6): ofab228.
-
2021Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 May; 2(5): 100275.
-
2021Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study., PLoS Med 2021 Apr; 18(4): e1003535.
-
2021Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients., Antimicrob Agents Chemother 2021 Mar; (): .
-
2021Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions., Clin Infect Dis 2021 Mar; (): .
-
+View full list of publications